Clinical trials: Type2diabetes
Type2diabetes
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Type 2 diabetes and metabolic (dysfunction)-associated fatty liver disease (MAFLD) often exist together. The prevalence of MAFLD is about 15-30% in healthy people and around 60-70% in people with type 2 diabetes.
- Trial name
- NCT06289387
- Where
- India
- Volunteers
- 1,000 people
- Sponsor
- Medanta, The Medicity, India
Type2diabetes
Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM
The Multi-center, randomized, controlled clinical trial investigate the efficacy and safety of Henagliflozin combined with continuous subcutaneous insulin infusion in newly diagnosed type 2 diabetes
- Trial name
- NCT05677334
- Testing
- Henagliflozin, Continuous Subcutaneous Insulin Infusion
- Where
- China
- Volunteers
- 210 people
- Sponsor
- First Affiliated Hospital of Guangxi Medical University